Core Insights - The company achieved total revenue of 302 million yuan in H1 2025, representing a year-on-year growth of 14.56%, with a net profit attributable to shareholders of 126 million yuan, up 1.26%, while the gross margin declined by 1.35 percentage points [1] - Domestic revenue faced short-term pressure, while overseas revenue showed steady growth, with 14 new overseas clients added in H1 2025 [1] - The company is focusing on independent innovation and enhancing its R&D capabilities, with R&D expenses reaching 344.6 million yuan, a 33.29% increase year-on-year, and an R&D expense ratio of 11.39% [1][2] Revenue Breakdown - Domestic revenue for H1 2025 was 140 million yuan, a 10.50% increase, accounting for 46.19% of total revenue, with a slight gross margin increase of 0.18 percentage points [1] - Overseas revenue reached 163 million yuan, growing by 18.28% and making up 53.81% of total revenue [1] R&D and Talent Development - The company expanded its R&D team to 187 personnel, a 47.24% increase year-on-year, with 42.25% holding bachelor's degrees and 40.11% holding master's degrees or higher [2] - The company obtained 45 new product registration certificates in H1 2025, including 26 new domestic and international registrations, supporting its global sales strategy [1] Future Projections - Revenue projections for 2025-2027 are 769 million, 942 million, and 1.147 billion yuan, with expected growth rates of 20.8%, 22.4%, and 21.8% respectively [2] - Net profit projections for the same period are 327 million, 387 million, and 464 million yuan, with growth rates of 11.6%, 18.1%, and 19.8% respectively [2]

Investment Rating - The report maintains an "Accumulate" rating for the company [5][11] Core Views - The company experienced a total revenue of 302 million yuan in H1 2025, representing a year-on-year growth of 14.56%, while the net profit attributable to shareholders was 126 million yuan, with a growth of 1.26%. The gross margin decreased by 1.35 percentage points [1][5] - Domestic performance is under short-term pressure, while overseas growth remains robust. The company is actively expanding its overseas partnerships and has added 14 new overseas clients in H1 2025 [1][2] - The company invested 344.6 million yuan in R&D in H1 2025, with an R&D expense ratio of 11.39%, an increase of 1.6 percentage points year-on-year, and R&D investment grew by 33.29% [2] Summary by Sections Financial Performance - In H1 2025, domestic revenue was 140 million yuan, up 10.50% year-on-year, accounting for 46.19% of total revenue, with a gross margin increase of 0.18 percentage points. Overseas revenue reached 163 million yuan, growing by 18.28% year-on-year, making up 53.81% of total revenue [1] - The company forecasts revenues of 769 million yuan, 942 million yuan, and 1.147 billion yuan for 2025, 2026, and 2027, respectively, with year-on-year growth rates of 20.8%, 22.4%, and 21.8% [2][3] R&D and Innovation - The company is focused on self-innovation and enhancing its R&D capabilities, with a total of 45 new product registrations in H1 2025, including 26 new registrations for domestic and international products [2] - The R&D personnel count reached 187, a year-on-year increase of 47.24%, with 42.25% holding bachelor's degrees and 40.11% holding master's degrees or higher [2] Future Outlook - The net profit attributable to shareholders is projected to be 327 million yuan, 387 million yuan, and 464 million yuan for 2025, 2026, and 2027, respectively, with growth rates of 11.6%, 18.1%, and 19.8% [3]